EFDID: 154933EFD: View Filing

Issuer: Verrica Pharmaceuticals Inc. (0001660334) - D

Accession: 0001140361-15-044797 (XMLRaw Data) (EDGAREDGAR Files) (Form DForm D)

EDGAR: Issuer Information
  • CIK:
    0001660334
  • Entity Name:
    Verrica Pharmaceuticals Inc.
  • Entity Type:
    Corporation
  • Jurisdiction:
    DELAWARE
  • Year of Inc:
    Within 5 years (2013)
  • Address:
    918 MCCUE AVENUE
    SAN CARLOS, CA 94070
  • Persons:
    Related Persons 5
    Matthew Davidson
    Executive Officer, Director
    Sean Stalfort
    Director
    Jayson Rieger
    Director
    Paul Manning
    Director
    Glenn Oclassen
    Director
EDGAR: Offering Information
  • Accession Date:
    12/16/2015
  • First Sale Date:
    12/02/2015
  • Offering Amount:
    Indefinite
  • Amount Sold:
    $2,434,186
  • Exemptions:
    Rule 506
  • Security Type(s):
    Equity
EFD: Current State Notices

No State Notices found in EFD

EDGAR: Sales Compensation Recipient Information
RecipientCRDBroker DealerBD CRDStates
IMS Health Capital, Inc. 150156 None None CA, MA, NY, VA
EDGAR: Signatures
IssuerSignatureSigner NameTitleSignatureDate
Verrica Pharmaceuticals Inc./s/ Matthew DavidsonMatthew DavidsonPresident and Chief Executive Officer2015-12-16